Avodart

*Does Avodart (Dutasteride) Allow Men on Intermittent Androgen Therapy To Have A Longer “Off Period”?

Researchers performed a randomized, placebo-controlled Phase II trial of men with localized prostate cancer and a rising prostate-specific antigen (PSA) level post-primary treatment. The men were randomized to receive Avodart (dutasteride @ 0.5 mg/day) or to receive a placebo. All of the men were receiving intermittent androgen deprivation therapy (IADT), which was stopped at month [...]

By Malecare|2015-02-17T15:32:35-05:00February 17th, 2015|2nd line hormone therapy, ADT, Advanced Prostate Cancer, Drugs & Treatments, Research, Uncategorized, Understanding APC|0 Comments

FDA: 5-Alpha-Reductase Inhibitors May Increase High-Grade Prostate Cancer Risk

There is a constant debate between both oncologist and advocates about the value and safety of 5-alpha-reductase inhibitors (Proscar and Avodart) both in the early treatment and later treatment of men with prostate cancer. In fact, I have had an on-going private debate with one very knowledgeable educator advocate over this issue. I often have [...]

By Malecare|2017-10-19T10:52:24-04:00June 23rd, 2011|Advanced Prostate Cancer, Drugs & Treatments, FDA, General Information, Politics of Cancer, Research, Uncategorized, Understanding APC|2 Comments

FDA Probes Breast Cancer Risk of Avodart & Proscar

The Food and Drug Administration (FDA) has announced that it is looking into reports that Glaxo Smith Kline’s prostate drug Avodart and Merck & Co’s prostate drug Proscar may be contributing to an increase of male breast cancers. […]

By Malecare|2017-10-19T10:54:02-04:00May 12th, 2010|Advanced Prostate Cancer, Drugs & Treatments, Hormone Therapy, Prostate Ponderings, Radiotherapy, Uncategorized, Understanding APC|5 Comments